Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L0ZF
|
||||
Former ID |
DNC003894
|
||||
Drug Name |
VESNARINONE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cardiac failure [ICD10:I50] | Approved | [551871] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H25N3O4
|
||||
Canonical SMILES |
COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)<br />OC
|
||||
InChI |
1S/C22H25N3O4/c1-28-19-7-3-16(14-20(19)29-2)22(27)25-11-9-24(10-12-25)17-5-6-18-15(13-17)4-8-21(26)23-18/h3,5-7,13-14H,4,8-12H2,1-2H3,(H,23,26)
|
||||
InChIKey |
ZVNYJIZDIRKMBF-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 81840-15-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | CGMP-inhibited 3',5'-cyclic phosphodiesterase A | Target Info | Inhibitor | [530575] | |
Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [526678] | ||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
References | |||||
Ref 526678 | Bioorg Med Chem Lett. 2003 Aug 18;13(16):2773-5.Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. | ||||
Ref 530575 | Bioorg Med Chem. 2010 Jan 15;18(2):855-62. Epub 2009 Nov 26.Design, synthesis and biological evaluation of 6-(benzyloxy)-4-methylquinolin-2(1H)-one derivatives as PDE3 inhibitors. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.